MCID: EVN001
MIFTS: 43

Evans' Syndrome malady

Categories: Rare diseases, Blood diseases, Immune diseases

Aliases & Classifications for Evans' Syndrome

Aliases & Descriptions for Evans' Syndrome:

Name: Evans' Syndrome 12 14
Evans Syndrome 50 56 52 42 69
Autoimmune Hemolytic Anemia and Autoimmune Thrombocytopenia 50 56
Immune Pancytopenia 56
Evan Syndrome 50

Characteristics:

Orphanet epidemiological data:

56
evans syndrome
Inheritance: Not applicable; Prevalence: 1-9/1000000 (Europe); Age of onset: Adult,Childhood;

Classifications:



External Ids:

Disease Ontology 12 DOID:8931
ICD10 33 D69.41
ICD9CM 35 287.32
MeSH 42 C536380
NCIt 47 C61284
SNOMED-CT 64 191315003 75331009
Orphanet 56 ORPHA1959
UMLS via Orphanet 70 C0272126
ICD10 via Orphanet 34 D69.3
UMLS 69 C0272126

Summaries for Evans' Syndrome

NIH Rare Diseases : 50 evans syndrome is a very rare autoimmune disorder in which the immune system destroys the body's red blood cells, white blood cells and/or platelets. affected people often experience thrombocytopenia (too few platelets) and coombs' positive hemolytic anemia (premature destruction of red blood cells). signs and symptoms may include purpura, paleness, fatigue, and light-headedness. the exact cause of this condition is unknown. the best treatment options for evans syndrome depend on many factors, including the severity of the condition; the signs and symptoms present; and each person's response to certain therapies. last updated: 5/18/2016

MalaCards based summary : Evans' Syndrome, also known as evans syndrome, is related to evans syndrome with immunodeficiency and premature immunosenescence and tylosis with esophageal cancer, and has symptoms including fatigue, dyspnea and syncope. An important gene associated with Evans' Syndrome is TPP2 (Tripeptidyl Peptidase 2). The drugs Efavirenz and Zidovudine have been mentioned in the context of this disorder. Affiliated tissues include t cells, thyroid and bone, and related phenotypes are hematopoietic system and immune system

Wikipedia : 71 Evans syndrome is an autoimmune disease in which an individual\'s antibodies attack their own red blood... more...

Related Diseases for Evans' Syndrome

Diseases related to Evans' Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 109)
id Related Disease Score Top Affiliating Genes
1 evans syndrome with immunodeficiency and premature immunosenescence 11.8
2 tylosis with esophageal cancer 11.6
3 autoimmune hemolytic anemia-autoimmune thrombocytopenia-primary immunodeficiency syndrome 10.8
4 stomatocytosis i 10.2 ADAMTS13 HP
5 thyroid cancer, anaplastic 10.2 ADAMTS13 HP
6 cutaneous polyarteritis nodosa 10.2 CD40LG HP
7 homocystinuria 10.2 CD40LG HP
8 pyelitis 10.1 ADAMTS13 HP
9 dysentery 10.1 CD40LG HP
10 central congenital hypothyroidism 10.1 ADAMTS13 CD40LG
11 spastic entropion 10.1 CD40LG HP
12 severe nonproliferative diabetic retinopathy 10.1 ADAMTS13 CD40LG
13 endogenous depression 10.1 CD40LG HP
14 pancreatic signet ring cell adenocarcinoma 10.1 ADAMTS13 CD40LG
15 voyeurism 10.1 CD40LG HP
16 lung combined large cell neuroendocrine carcinoma 10.1 CD40LG HP
17 choreatic disease 10.1 CD40LG HP
18 ocular hyperemia 10.1 ADAMTS13 CD40LG
19 ciliary body spindle cell melanoma 10.1 CD40LG MAGT1
20 chronic progressive external ophthalmoplegia 10.1 ADAMTS13 CD40LG
21 gestational diabetes 10.1 CD40LG MAGT1
22 pseudohypoaldosteronism, type iic 10.1 CD40LG MAGT1
23 sertoli-leydig cell tumor 10.0 ADAMTS13 CD40LG
24 vaginal glandular tumor 10.0 CD40LG HP
25 gluten allergy 10.0 ADAMTS13 CD40LG HP
26 haemonchiasis 10.0 ADAMTS13 CD40LG
27 perichondritis of auricle 10.0 ADAMTS13 CD40LG
28 nonspecific interstitial pneumonia 10.0 CD40LG HP
29 lambda 5 deficiency 10.0 CD3G CD40LG
30 ectopic thymus 10.0 CD3G CD40LG
31 lymphoma 10.0
32 hemolytic anemia 9.9
33 myeloproliferative neoplasm 9.9 ADAMTS13 CD40LG
34 pancytopenia 9.8
35 autoimmune hemolytic anemia 9.8
36 neuropathy, hereditary thermosensitive 9.8 CD3G CD40LG SMARCAL1
37 common variable immunodeficiency 9.8
38 hepatitis 9.8
39 pure red-cell aplasia 9.8
40 purpura 9.8
41 thyroiditis 9.8
42 hodgkin lymphoma 9.7
43 autoimmune lymphoproliferative syndrome 9.7
44 autoimmune hepatitis 9.7
45 thrombocytopenia 9.7
46 lymphoproliferative syndrome 9.7
47 nocardiosis 9.7
48 adenoma 9.7
49 digeorge syndrome 9.5
50 myocardial infarction 9.5

Graphical network of the top 20 diseases related to Evans' Syndrome:



Diseases related to Evans' Syndrome

Symptoms & Phenotypes for Evans' Syndrome

Human phenotypes related to Evans' Syndrome:

56 32 (show all 13)
id Description HPO Frequency Orphanet Frequency HPO Source Accession
1 fatigue 56 32 Frequent (79-30%) HP:0012378
2 dyspnea 56 32 Frequent (79-30%) HP:0002094
3 syncope 56 32 Occasional (29-5%) HP:0001279
4 muscle weakness 56 32 Frequent (79-30%) HP:0001324
5 lethargy 56 32 Frequent (79-30%) HP:0001254
6 pallor 56 32 Frequent (79-30%) HP:0000980
7 jaundice 56 32 Frequent (79-30%) HP:0000952
8 epistaxis 56 32 Frequent (79-30%) HP:0000421
9 bruising susceptibility 56 32 Frequent (79-30%) HP:0000978
10 petechiae 56 32 Very frequent (99-80%) HP:0000967
11 autoimmune hemolytic anemia 56 32 Obligate (100%) HP:0001890
12 autoimmune thrombocytopenia 56 32 Obligate (100%) HP:0001973
13 autoimmune neutropenia 56 32 Very frequent (99-80%) HP:0001904

MGI Mouse Phenotypes related to Evans' Syndrome:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 9.43 ADAMTS13 CD3G CD40LG HP SMARCAL1 TPP2
2 immune system MP:0005387 9.1 CD40LG HP SMARCAL1 TPP2 ADAMTS13 CD3G

Drugs & Therapeutics for Evans' Syndrome

Drugs for Evans' Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 144)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Efavirenz Approved, Investigational Phase 4,Phase 2 154598-52-4 64139
2
Zidovudine Approved Phase 4,Phase 3,Phase 2 30516-87-1 35370
3
Lamivudine Approved, Investigational Phase 4,Phase 3,Phase 2 134678-17-4 60825
4
Hydroxyurea Approved Phase 4 127-07-1 3657
5
Didanosine Approved Phase 4 69655-05-6 50599
6
Stavudine Approved, Investigational Phase 4 3056-17-5 18283
7
Abacavir Approved, Investigational Phase 4,Phase 3 136470-78-5 65140 441300
8
Acetylcholine Approved Phase 4 51-84-3 187
9
protease inhibitors Phase 4,Phase 3
10 HIV Protease Inhibitors Phase 4,Phase 3
11 Cytochrome P-450 Enzyme Inhibitors Phase 4,Phase 3,Phase 2
12 Peripheral Nervous System Agents Phase 4,Early Phase 1
13 Anti-HIV Agents Phase 4,Phase 3,Phase 2
14 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1
15 Anti-Retroviral Agents Phase 4,Phase 3,Phase 2
16 Antiviral Agents Phase 4,Phase 3,Phase 2,Phase 1
17 Cytochrome P-450 CYP2C9 Inhibitors Phase 4,Phase 2
18 Cytochrome P-450 CYP3A Inducers Phase 4,Phase 3,Phase 2
19 Nucleic Acid Synthesis Inhibitors Phase 4,Phase 3,Phase 2
20 Antimetabolites Phase 4,Phase 3,Phase 2
21 Reverse Transcriptase Inhibitors Phase 4,Phase 3,Phase 2
22 Cholinergic Agents Phase 4
23 Neuromuscular Agents Phase 4
24 Neurotransmitter Agents Phase 4
25 abobotulinumtoxinA Phase 4
26 incobotulinumtoxinA Phase 4
27 onabotulinumtoxinA Phase 4
28 Botulinum Toxins Phase 4
29 Botulinum Toxins, Type A Phase 4
30
Ritonavir Approved, Investigational Phase 3 155213-67-5 392622
31
Lopinavir Approved Phase 3 192725-17-0 92727
32
Fosamprenavir Approved Phase 3 226700-79-4 131536
33
Estradiol Approved, Investigational, Vet_approved Phase 3 50-28-2 5757 53477783
34
Indinavir Approved Phase 3 150378-17-9 5362440
35
Amprenavir Approved Phase 3 161814-49-9 65016
36
Rifampin Approved Phase 3 13292-46-1 5458213 5381226
37
Isoniazid Approved Phase 3 54-85-3 3767
38
Pyrazinamide Approved Phase 3 98-96-4 1046
39
Norgestimate Approved Phase 3 35189-28-7 6540478
40
Moxifloxacin Approved, Investigational Phase 3 354812-41-2, 151096-09-2 152946
41
Ethambutol Approved Phase 3 74-55-5 3279 14052
42
Loteprednol Approved Phase 3,Phase 2 82034-46-6, 129260-79-3 444025 9865442
43
Ethinyl Estradiol Approved Phase 3 57-63-6 5991
44
Pitavastatin Approved Phase 3 147511-69-1, 147526-32-7 6366718 5282452
45 Cytochrome P-450 CYP3A Inhibitors Phase 3,Phase 2
46 Estradiol valerate Phase 3 979-32-8
47 Contraceptive Agents Phase 3
48 Contraceptives, Oral Phase 3
49 Contraceptives, Oral, Combined Phase 3
50 Norgestimate, ethinyl estradiol drug combination Phase 3

Interventional clinical trials:

(show all 48)
id Name Status NCT ID Phase
1 Safety and Effectiveness of a Combination Anti-HIV Drug Treatment Completed NCT00005018 Phase 4
2 Intravesicular Onabotulinumtoxin A in Interstitial Cystitis Recruiting NCT02297100 Phase 4
3 Comparison of Two Dosing Regimens of GW433908/Ritonavir Versus Lopinavir/Ritonavir for 48 Weeks in HIV Patients Who Have Taken Protease Inhibitors and Experienced Virological Failure Unknown status NCT00025727 Phase 3
4 Rilonacept for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS) Completed NCT00288704 Phase 3
5 Controlled Comparison of Two Moxifloxacin Containing Treatment Shortening Regimens in Pulmonary Tuberculosis Completed NCT00864383 Phase 3
6 The Safety and Effectiveness of Lamivudine Plus Zidovudine, Used With and Without 1592U89, in HIV-1 Infected Patients Who Have Never Taken Anti-HIV Drugs Completed NCT00002389 Phase 3
7 A Comparison of 141W94 and Indinavir in HIV-Infected Patients Completed NCT00002202 Phase 3
8 Safety and Efficacy of KPI-12 in Subjects With Dry Eye Disease Recruiting NCT02813265 Phase 3
9 Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Recruiting NCT00719303 Phase 3
10 Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease Recruiting NCT02819284 Phase 3
11 Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults Recruiting NCT02344290 Phase 3
12 Using Human Menstrual Blood Cells to Treat Acute Lung Injury Caused by H7N9 Bird Flu Virus Infection Unknown status NCT02095444 Phase 1, Phase 2
13 Acute Human Study: StimRouter for Peripheral Nerve Stimulation of Discrete Peripheral Nerves Completed NCT00665132 Phase 1, Phase 2
14 Hyperbaric Oxygen Therapy (HBO2) for Persistent Post-concussive Symptoms After Mild Traumatic Brain Injury (mTBI) Completed NCT01306968 Phase 2
15 Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease Completed NCT02188160 Phase 2
16 Safety and Effectiveness of Lamivudine When Given Once a Day Versus Twice a Day in Combination With Other Anti-HIV Drugs in HIV-Infected Adults Who Have Never Received Anti-HIV Drugs Completed NCT00004852 Phase 2
17 Evaluation of the Efficacy of Two Probiotic Strains for Irritable Bowel Syndrome Recruiting NCT02213172 Phase 2
18 Effect of D-allulose in Addition to Oral Sucrose Load Recruiting NCT02714413 Phase 2
19 Open-label Trial of SUBA™-Itraconazole (SUBA-Cap) in Subjects With Basal Cell Carcinoma Nevus Syndrome (BCCNS) Recruiting NCT02354261 Phase 2
20 Vitamin C Infusion for Treatment in Sepsis Induced Acute Lung Injury Recruiting NCT02106975 Phase 2
21 Sirolimus for Autoimmune Disease of Blood Cells Active, not recruiting NCT00392951 Phase 1, Phase 2
22 Treatment of Autoimmune Thrombocytopenia (AITP) Completed NCT00001630 Phase 1
23 Higher Protein Diet and Exercise for Optimal Weight Loss in Elderly Women Completed NCT00912210 Phase 1
24 A Multicenter, Randomized, Placebo-Controlled, Double-Blinded, Phase I Trial to Evaluate the Safety and Immunogenicity of Live Recombinant Canarypox ALVAC-HIV vCP205 Combined With GM-CSF in Healthy, HIV-1 Uninfected Volunteers Completed NCT00001090 Phase 1
25 An Investigational Combination Vaccine Given to People Who Are Not Infected With HIV Completed NCT00027365 Phase 1
26 A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of HIV-1 MN rsgp120 and Bivalent AIDSVAX B/E (HIV-1 MN rgp120/A244 rgp120) in Combination With QS-21 With or Without Alum in Healthy HIV-1 Completed NCT00001096 Phase 1
27 A Study of the Effectiveness of an HIV Vaccine (ALVAC vCP205) to Boost Immune Functions in HIV-Negative Volunteers Who Have Already Received an HIV Vaccine Completed NCT00001136 Phase 1
28 A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP300 and HIV-1 SF-2 rgp120 in HIV-1 Uninfected Adult Volunteers Completed NCT00001072 Phase 1
29 A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of Low Dose MN rsgp120/HIV-1 (Genentech) in Combination With QS21 Adjuvant or Alum in Healthy Adults Completed NCT00000853 Phase 1
30 The Role of Lipoaspirate Injection in the Treatment of Diabetic Lower Extremity Wounds and Venous Stasis Ulcers Unknown status NCT00815217
31 Effect of a High-Protein Diet and/or High-Intensity Training on Metabolic Syndrome Completed NCT01622634
32 Iyengar Yoga for Young People With Irritable Bowel Syndrome Completed NCT01107977
33 Randomized Study of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Women With Polycystic Ovary Syndrome Completed NCT00005104
34 Randomized Study of the Effect of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Obese Women With Polycystic Ovary Syndrome Completed NCT00005654
35 New Markers to Measure Clotting in Patients With the Obstructive Sleep Apnoea Hypopnoea Syndrome Completed NCT01525160
36 Exercise-Induced Epigenetic Modifications in Obese Aging Women Completed NCT01977885
37 Study of Effects of Sutures on Results of Palate Surgery for Obstructive Sleep Apnea Completed NCT00205543
38 The Effectiveness of Human Antibodies in Influencing an AIDS-Like Disease in Monkeys Completed NCT00031109
39 A Comparison of Epivir Plus Crixivan Combined With Zerit or Retrovir in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs Completed NCT00002369
40 Rivaroxaban ACS Specialist Cohort Event Monitoring Study Recruiting NCT02673437
41 Remifentanil in Adults With OSA Recruiting NCT02898792 Early Phase 1
42 Patients Treated for Wiskott-Aldrich Syndrome (WAS) Since 1990 Recruiting NCT02064933
43 Natural History Study of SCID Disorders Recruiting NCT01186913
44 Patients Treated for SCID (1968-2010) Recruiting NCT01346150
45 Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995 Recruiting NCT02082353
46 Normative Datasets for Assessments Planned for Mild Traumatic Brain Injury (NORMAL) Active, not recruiting NCT01925963
47 mTBI Mechanisms of Action of HBO2 for Persistent Post-Concussive Symptoms Active, not recruiting NCT01611194
48 MED-C Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice Not yet recruiting NCT02900248

Search NIH Clinical Center for Evans' Syndrome

Cochrane evidence based reviews: evans syndrome

Genetic Tests for Evans' Syndrome

Anatomical Context for Evans' Syndrome

MalaCards organs/tissues related to Evans' Syndrome:

39
T Cells, Thyroid, Bone, B Cells, Prostate, Pancreas, Pituitary

Publications for Evans' Syndrome

Articles related to Evans' Syndrome:

(show top 50) (show all 67)
id Title Authors Year
1
Persistent Fever in Medical Intensive Care Unit: Evans Syndrome Versus Actinomycotic Osteomyelitis? ( 28092284 )
2017
2
Evans syndrome with non-ST segment elevation myocardial infarction complicated by hemopericardium. ( 27751316 )
2016
3
Evans syndrome after autologous peripheral blood stem cell transplantation for recurrent Hodgkin lymphoma. ( 27577012 )
2016
4
Unusual co-occurrence of Evans syndrome and pure red cell aplasia in elderly patient with prostate cancer. ( 27465154 )
2016
5
Evans Syndrome Secondary to Common Variable Immune Deficiency. ( 26950085 )
2016
6
Disseminated intravascular coagulation and immune hemolytic anemia, possibly evans syndrome, after oxaliplatin and bevacizumab infusion for metastatic colon adenocarcinoma: a case report and literature review. ( 25600448 )
2015
7
Early-onset Evans syndrome, immunodeficiency, and premature immunosenescence associated with tripeptidyl-peptidase II deficiency. ( 25414442 )
2015
8
Successful treatment with rituximab and romiplostim for thrombocytopenia associated with WaldenstrAPm's macroglobulinemia initially presenting as Evans syndrome. ( 25876786 )
2015
9
A Case of a TSH-secreting Pituitary Adenoma Associated with Evans' Syndrome. ( 26150183 )
2015
10
Profound autoimmune hemolysis and Evans syndrome in two asplenic patients with babesiosis. ( 25354478 )
2014
11
Autoimmune hepatitis-primary biliary cirrhosis overlap syndrome concomitant with immune hemolytic anemia and immune thrombocytopenic purpura (Evans syndrome). ( 23273499 )
2013
12
Evaluation of children with chronic immune thrombocytopenic purpura and Evans syndrome treated with rituximab. ( 22815318 )
2013
13
A case of Evans' syndrome following influenza vaccine. ( 22796025 )
2013
14
CD56+ angioimmunoblastic T-cell lymphoma with evans syndrome : a case report and review of the literature. ( 23801132 )
2013
15
Hashimoto's thyroiditis associated Evans syndrome: A rare case report on the clustered autoimmune disease triad. ( 23961497 )
2013
16
Refractory thrombocytopenia responds to octreotide treatment in a case of evans syndrome with gastric neuroendocrine tumor. ( 23984123 )
2013
17
Evans syndrome with cytomegalovirus infection followed by emerging peripheral T-cell lymphoma. ( 21437588 )
2012
18
Dermatomyositis associated with generalized subcutaneous edema and Evans syndrome. ( 22030016 )
2012
19
Successful allogeneic cord blood transplantation in a patient with Evans syndrome leads to correction of hereditary angioedema type I as secondary effect. ( 22327128 )
2012
20
Successful control of steroid-intolerant Evans' syndrome associated with allogeneic peripheral blood hematopoietic stem cell transplant by rituximab. ( 21275632 )
2011
21
Massive hemoperitoneum with splenic infarction in Evans syndrome. ( 21088621 )
2011
22
Successful rituximab therapy in refractory autoimmune hepatitis and Evans syndrome. ( 22446656 )
2011
23
Evans syndrome following long-standing Hashimoto's thyroiditis and successful treatment with rituximab. ( 22259635 )
2011
24
Successful remission of Evans syndrome associated with Graves' disease by using propylthiouracil monotherapy. ( 21422690 )
2011
25
Rituximab resistant evans syndrome and autoimmunity in Schimke immuno-osseous dysplasia. ( 21914180 )
2011
26
Glucocorticoid-resistant Evans' syndrome successfully controlled with low-dose cyclosporine. ( 21961487 )
2011
27
Howel-Evans syndrome: a variant of ectodermal dysplasia. ( 20486456 )
2010
28
Evans' syndrome in pregnancy: a systematic literature review and two new cases. ( 20031296 )
2010
29
Identifying autoimmune lymphoproliferative syndrome in children with Evans syndrome: a multi-institutional study. ( 20068224 )
2010
30
Complications of Evans' syndrome in an infant with hereditary spherocytosis: a case report. ( 19740448 )
2009
31
Visceral leishmaniasis in a patient with common variable immunodeficiency and evans syndrome: clinical remarks. ( 19579705 )
2009
32
Amyloidosis, Evans syndrome and management options of lymphoplasmacytic lymphoma. ( 19291514 )
2009
33
Splenic marginal zone lymphoma with Evans' syndrome, autoimmunity, and peripheral gamma/delta T cells. ( 18665362 )
2009
34
Treatment of Evans' syndrome with human intravenous immunoglobulin and leflunomide in a diabetic dog. ( 19411652 )
2009
35
Primary cutaneous nocardiosis in a patient with Evans' Syndrome. ( 19661017 )
2009
36
Pseudohypoparathyroidism Ia with Evans syndrome. ( 18799944 )
2008
37
Consolidation treatment with rituximab induces complete and persistent remission of mixed type Evans syndrome. ( 18469554 )
2008
38
Common variable immunodeficiency and Evans syndrome complicated by autoimmune hemolysis due to anti-Jka auto-antibodies. ( 18452064 )
2008
39
A dose-escalation study of rituximab for treatment of systemic lupus erythematosus and Evans' syndrome: immunological analysis of B cells, T cells and cytokines. ( 18397955 )
2008
40
Increased lymphocyte Fas expression and high incidence of common variable immunodeficiency disorder in childhood Evans' syndrome. ( 17936685 )
2007
41
A case of pure red cell aplasia complicated by Evans syndrome. ( 17694270 )
2007
42
Autoimmune hemolytic anemias, Evans' syndromes, and pure red cell aplasia in non-Hodgkin lymphomas. ( 17577777 )
2007
43
Development of mixed-type autoimmune hemolytic anemia and Evans' syndrome following chicken pox infection in a case of low-titer cold agglutinin disease. ( 17050195 )
2006
44
Tubercular adenitis and Evans' syndrome. ( 16539285 )
2006
45
A 20-year-old woman with Hashimoto's thyroiditis and Evans' syndrome. ( 16807996 )
2006
46
Unmasking Evans syndrome: T-cell phenotype and apoptotic response reveal autoimmune lymphoproliferative syndrome (ALPS). ( 15542578 )
2005
47
Successful treatment of a patient with mixed warm and cold antibody mediated Evans syndrome and glucose intolerance. ( 15704210 )
2005
48
Pegylated interferon alpha-2a-associated life-threatening Evans' syndrome in a patient with chronic hepatitis C. ( 16230187 )
2005
49
Fatal Evans' syndrome after matched unrelated donor transplantation for hyper-IgM syndrome. ( 15128425 )
2004
50
An infant with I^-globulin-induced hypersensitivity syndrome who developed Evans' syndrome after a second I^-globulin treatment. ( 24387652 )
2004

Variations for Evans' Syndrome

Expression for Evans' Syndrome

Search GEO for disease gene expression data for Evans' Syndrome.

Pathways for Evans' Syndrome

GO Terms for Evans' Syndrome

Biological processes related to Evans' Syndrome according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 T cell costimulation GO:0031295 8.62 CD3G CD40LG

Sources for Evans' Syndrome

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....